Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial.
Sign Up to like & getrecommendations! Published in 2020 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2019.6584
Abstract: Importance Active therapeutic combinations, such as trabectedin and radiotherapy, offer potentially higher dimensional response in second-line treatment of advanced soft-tissue sarcomas. Dimensional response can be relevant both for symptom relief and for survival. Objective To… read more here.
Keywords: phase; metastatic soft; soft tissue; radiotherapy ... See more keywords
Impact of surgery in patients with metastatic soft tissue sarcoma: A monocentric retrospective analysis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25115
Abstract: The role of local surgical procedures in patients with metastatic soft tissue sarcoma is still undefined. Few retrospective studies have reported survival benefits for patients with pulmonary metastases after complete surgical resection. Treatment decisions are… read more here.
Keywords: soft tissue; metastatic soft; tissue sarcoma; patients metastatic ... See more keywords
Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study
Sign Up to like & getrecommendations! Published in 2017 at "BMC Medicine"
DOI: 10.1186/s12916-017-0831-7
Abstract: BackgroundWell-designed observational studies of individuals with rare tumors are needed to improve patient care, clinical investigations, and the education of healthcare professionals.MethodsThe patterns of care, outcomes, and prognostic factors of a cohort of 2225 patients… read more here.
Keywords: metastatic soft; treatment; care outcomes; patients metastatic ... See more keywords
Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e22550
Abstract: e22550 Background: Olaratumab is a humanized monoclonal anti platelet-derived growth factor receptor α antibody that has been approved in combination with doxorubicin for the treatment of patients with metastatic soft tissue sarcoma (STS). The purpose… read more here.
Keywords: tissue sarcoma; metastatic soft; world; soft tissue ... See more keywords
Clinical observation of local intervention combined with camrelizumab and apatinib in the treatment of metastatic soft-tissue sarcoma
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cancer Research and Therapeutics"
DOI: 10.4103/jcrt.jcrt_1310_21
Abstract: Aims: The study aimed to investigate the effectiveness and safety of the combination of immune checkpoint inhibitor, local interventional therapy, and anti-angiogenic therapy in patients with metastatic soft-tissue sarcoma (mSTS). Settings and Design: We retrospectively… read more here.
Keywords: tissue sarcoma; metastatic soft; combined camrelizumab; treatment ... See more keywords